New Drug Duo Significantly Slows Progression of Aggressive Breast Cancer

Phase 3 trial shows sacituzumab govitecan and pembrolizumab outperform standard treatment in triple-negative breast cancer

New Drug Significantly Improves Outcomes for Patients with Polycythemia Vera

The therapy reduces the need for the therapeutic removal of blood and improves symptoms

Reduce Your Risk of Lung Cancer - Quit Smoking for World No Tobacco Day

Studies show 80% of lung cancer cases are a result of smoking

Researchers Explore New Treatment for Aggressive Head and Neck Cancer

Early clinical trial results suggest dual drug therapy may improve survival for patients with HPV-negative head and neck cancer

Young TikTok Star Shares Glioblastoma Journey

Anna Grace Phelan died from the rare and aggressive brain cancer at 19

Study Looks To Improve TIL Therapy for Advanced Melanoma

TIL therapy can be used to treat advanced melanoma when patients do not respond to standard treatment options

Immunotherapy Combo Shows Promise as Pre-Surgical Treatment for Merkel Cell Carcinoma

More than half of patients had no detectable tumor cells after treatment with pembrolizumab and lenvatinib

GLP-1 Drugs May Lower Risk of Obesity-Related Cancers in People With Diabetes

Study suggests modest protective effect, especially in women

Testing a Triple Threat Drug Combo Against Kidney Cancer

Trial looks at whether combining treatments can better stop kidney cancer from growing

Endeavor